“These results have significant policy implications, particularly with respect to the use of traditional workplace drug testing. It is high-time to abandon these discriminatory methods in favor of performance testing and fit-for-duty testing, which employ measures to assess whether someone is currently under the influence, whether it be from marijuana on anything else.”
Researchers reported that those with a history of cannabis use “demonstrated significantly better cognitive performance.” Cannabis use “was not associated with increased risk of dementia” and researchers found “no supporting evidence of a causal link with [longitudinal] cognitive decline in later life.”
“This study adds to a growing body of evidence that cannabis use may be associated with greater brain volume and cognitive performance in aging adults.”
Researchers described cannabis’ efficacy as “superior” to those of traditional Alzheimer’s medications.
“Our results indicate that older adults who reported using cannabis in the prior six months did not differ on neuropsychological testing results when compared to older adults who reported no recent use of cannabis.”
“These findings add to the growing body of evidence that cannabis is effective in the treatment of multiple conditions, including chronic pain, and that it possesses a safety profile that is often superior to traditional medications, like opioids.”
Researchers determined that participants with a history of cannabis use experienced “significantly less cognitive decline” over their lifetimes than did non-users.
“Our results suggest that adults who use cannabis … experience few significant long-term neural associations in these areas of cognition.”